Parnell Pharmaceuticals

^{Priced, Nasdaq: PARN}

Australian maker of osteoarthritis and reproductive drugs for dogs, horses and cows.

Industry: Health Care

First Day Return: -19.5%

PARN

Australian maker of osteoarthritis and reproductive drugs for dogs, horses and cows.

IPO News for Parnell Pharmaceuticals

Dog diarrhea deal drops out: Jaguar Animal Health postpones IPO 11/05/14
Year's number 2 IPO: Dog diarrhea biotech Jaguar Animal Health sets terms for $40 million IPO 10/28/14
Parnell Pharmaceuticals prices IPO at $10, well below the original range 06/18/14

IPO Data
IPO Date	06/18/2014
Offer Price	IPO Intelligence Only
Price Range	IPO Intelligence Only
Offer Shares (mm)	IPO Intelligence Only
Deal Size ($mm)	$50
Lock-Up Date	IPO Intelligence Only
Street Research	IPO Intelligence Only

Underwriters
IPO Intelligence Only

Company Data
Website www.parnell.com
Headquarters	Alexandria, Australia
Founded	1986
Employees at IPO	55

IPO News for Parnell Pharmaceuticals

Parnell Pharmaceuticals (PARN) Performance